In general, evidence has accumulated that DLX3 plays a pleiotropic role in several biological process to maintain bone homeostasis in normal bone, whereas, in TDO patients, this homeostasis is jeopardized by DLX3 mutation through triggering different pathways in the regulatory network to rectify this mistake. This evidence concerns the gene DLX3 and tricho-dento-osseous syndrome.